Skip to content

Company information lookup


The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory disorders.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PXS 0.047 0% 0.047 0.049 0.000 0.000 0.000 0


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PXS
Official Listing Date 10 November, 2003
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address 20 Rodborough Road, FRENCHS FOREST, NSW, AUSTRALIA, 2086
Head Office Telephone (02) 9454 7200
Head Office Fax (02) 9451 3622
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Malcolm McComas (Chairman)
Mr Gary Jonathan Phillips (CEO, Director)
Dr Simon Hugh William Buckingham (Independent Director)
Mr Will Delaat (Independent Director)
Mr David McGarvey (CFO, Investor Relations)
Company Secretary Mr David McGarvey
Principal Activities The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory disorders.

PHARMAXIS LTD announcements

How are company announcements published on

Date Price
Headline Pages PDF
15/10/2014   Appendix 3B - Exercise of Employee Options 14 PDF
08/09/2014   Appendix 3B - Exercise of Employee Options 13 PDF
08/09/2014 asterix New data from B305 clinical trial presented at ERS 2 PDF
28/08/2014   Quarter 4 Shareholder Update 7 PDF
28/08/2014 asterix Preliminary Final Report, Financial and Directors' Report 87 PDF
28/08/2014 asterix SSAO Inhibitor Ready for the Clinic 2 PDF
04/08/2014 asterix Pharmaxis Files Lawsuit Against NovaQuest 2 PDF
30/07/2014 asterix Appendix 4C - quarterly 5 PDF
08/07/2014 asterix Update On Timing Of Pre-Clinical Partnering Projects 2 PDF
08/07/2014 asterix Communication from Financier NovaQuest 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Oct 2014 0.047 -2.08% 0.047 0.045 230,298
21 Oct 2014 0.048 -4% 0.050 0.045 322,500
20 Oct 2014 0.050 -3.85% 0.052 0.050 31,380
17 Oct 2014 0.052 4% 0.053 0.050 56,740
16 Oct 2014 0.050 0% 0.051 0.050 214,801

* Volume of shares shown represents only those shares traded on ASX.

PHARMAXIS LTD price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security PXS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PXS

Warrants & Structured Products

No warrants & Structured Products are available over the security PXS